Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AN2 Therapeutics, Inc. | 225,000 | reported | 19 Mar 2026 | tx 43+2,478,706−844,564 |
1 purchase reported after at least 12 months of silence — most recent on 18 Nov 2024.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Mar 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 267,650 | — | deriv |
| 19 Mar 2026 | OTHER | AN2 Therapeutics, Inc. | 225,000 | — | deriv |
| 19 Mar 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 225,000 | — | deriv |
| 19 Mar 2026 | OTHER | AN2 Therapeutics, Inc. | 249,999 | — | deriv |
| 19 Mar 2026 | OTHER | AN2 Therapeutics, Inc. | 267,650 | — | deriv |
| 19 Mar 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 249,999 | — | deriv |
| 20 Feb 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 112,250 | 0.00 USD | |
| 20 Feb 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 224,500 | 0.00 USD | deriv |
| 02 Jun 2025 | PURCHASE | AN2 Therapeutics, Inc. | 10,000 | 1.07 USD | |
| 26 Feb 2025 | GRANT_AWARD | AN2 Therapeutics, Inc. | 145,250 | 0.00 USD | |
| 26 Feb 2025 | GRANT_AWARD | AN2 Therapeutics, Inc. | 290,500 | 0.00 USD | deriv |
| 18 Nov 2024 | PURCHASE | AN2 Therapeutics, Inc. | 50,000 | 1.00 USD | first after silence |
| 15 Mar 2024 | GRANT_AWARD | AN2 Therapeutics, Inc. | 99,000 | 0.00 USD | |
| 15 Mar 2024 | GRANT_AWARD | AN2 Therapeutics, Inc. | 198,000 | 0.00 USD | deriv |
| 02 Jan 2024 | SALE | AN2 Therapeutics, Inc. | 2,777 | 20.09 USD | |
| 15 May 2023 | PURCHASE | AN2 Therapeutics, Inc. | 10,000 | 5.38 USD | |
| 23 Feb 2023 | GRANT_AWARD | AN2 Therapeutics, Inc. | 267,650 | 0.00 USD | deriv |
| 10 Nov 2022 | SALE | AN2 Therapeutics, Inc. | 4,413 | 15.32 USD | |
| 14 Nov 2022 | SALE | AN2 Therapeutics, Inc. | 23 | 15.04 USD | anomaly |
| 08 Nov 2022 | SALE | AN2 Therapeutics, Inc. | 1,255 | 16.38 USD | |
| 08 Nov 2022 | SALE | AN2 Therapeutics, Inc. | 5,800 | 15.41 USD | |
| 09 Nov 2022 | SALE | AN2 Therapeutics, Inc. | 10,111 | 15.61 USD | |
| 03 Nov 2022 | SALE | AN2 Therapeutics, Inc. | 11,082 | 15.67 USD | |
| 07 Nov 2022 | SALE | AN2 Therapeutics, Inc. | 2,036 | 16.72 USD | |
| 03 Nov 2022 | SALE | AN2 Therapeutics, Inc. | 3,083 | 16.02 USD |